JUST IN: Hope for Kenyans as KEMRI recommends new HIV prevention drugs 

  Research scientists have asked the government of Kenya to hasten the process of approving two new drugs that study have the highest efficacy of preventing HIV. The researchers at the Kenya Medical Research institute (KEMRI) want the pharmacy and poisons board to approve Cabotegravir and Lenacapavir to ease the burden for HIV in the country.
The post Hope for Kenyans as KEMRI recommends new HIV prevention drugs appeared first on TV47 Digital. Read More